ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHRYSOLOGUE GAKUBA M.D.

Cardiovascular Disease

16,870

$1.39M

321
310 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 28%

$83
Average prescription price

Avg: $84

ERNESTO AFRICANO M.D.

Cardiovascular Disease

8,042

$399K

357
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $84

TODD NOREUIL MD

Cardiovascular Disease

7,233

$320K

618
564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $84

ANTHONY FREY M.D.

Cardiovascular Disease

6,990

$383K

581
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $84

DONALD WOOD M.D.

Cardiovascular Disease

6,606

$452K

802
712 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $84

STEVEN TEE M.D.

Cardiovascular Disease

6,571

$815K

303
241 are 65+

9%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$124
Average prescription price

Avg: $84

JOHN VITARELLO M.D.

Cardiovascular Disease

5,664

$460K

672
597 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $84

RAYMON NELSON MD

Cardiovascular Disease

5,269

$674K

191
147 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$128
Average prescription price

Avg: $84

LUCY VANVOORHEES M.D.

Cardiovascular Disease

5,168

$391K

625
576 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $84

KUSAY BARAKAT M.D.

Cardiovascular Disease

5,079

$429K

541
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$85
Average prescription price

Avg: $84

EMERSON WALDEN M.D.

Cardiovascular Disease

5,032

$276K

186
175 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $84

HITESH PATEL MD

Cardiovascular Disease

4,712

$375K

480
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $84

DINESH KALARIA M.D.

Cardiovascular Disease

4,355

$345K

450
421 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $84

DAVID GOORAY MD

Cardiovascular Disease

4,033

$427K

206
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $84

BRIAN KAHN MD

Cardiovascular Disease

3,894

$267K

534
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $84

BRENDON PALTOO MD

Cardiovascular Disease

3,872

$150K

311
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$39
Average prescription price

Avg: $84

JERALD INSEL M.D.

Cardiovascular Disease

3,867

$341K

478
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $84

ROMULO BALTAZAR M.D.

Cardiovascular Disease

3,714

$162K

133
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $84

STEPHEN PLANTHOLT M.D.

Cardiovascular Disease

3,697

$235K

433
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $84

JOHN MARRA M.D.

Cardiovascular Disease

3,488

$228K

262
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $84

DENNIS CHODNICKI M.D.

Cardiovascular Disease

3,420

$252K

461
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $84

DAVID RUBIN MD

Cardiovascular Disease

3,416

$292K

456
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$86
Average prescription price

Avg: $84

RAMESH AGARWAL MD

Cardiovascular Disease

3,365

$169K

245
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $84

DENNIS FRIEDMAN M.D.

Cardiovascular Disease

3,327

$365K

411
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 28%

$110
Average prescription price

Avg: $84

MICHAEL LEVANGIE MD

Cardiovascular Disease

3,229

$305K

312
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$94
Average prescription price

Avg: $84

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank